Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic

BSE655.95-20.3 (-3 %)

PREV CLOSE ( ) 676.25

OPEN PRICE ( ) 671.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3392

TODAY'S LOW / HIGH ( )650.40 671.50

52 WK LOW / HIGH ( )635.3 1107.8

NSE656.20-20.85 (-3.08 %)

PREV CLOSE( ) 677.05

OPEN PRICE ( ) 666.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 60922

TODAY'S LOW / HIGH( ) 650.00 673.55

52 WK LOW / HIGH ( )635.8 1107.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-06 2010

Management Info

Chirayu Amin - Chairman Shaunak Amin - Managing Director

Registered Office

Address Alembic Road, , ,
Vadodara,
Gujarat-390003

Phone 0265 - 2280550 / 2280880

Email alembic@alembic.co.in

Website www.alembicpharmaceuticals.com

Registrars Details

MUFG Intime India Pvt Ltd.

Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara

Listing : BSE, NSE

NEWS

01Apr Alembic Pharmaceuticals informs about
Alembic Pharmaceuticals has informed that based on the recommendation of..

27Mar Alembic Pharma gets USFDA’s final nod
Alembic Pharmaceuticals (Alembic) has received final approval from the U..

10Mar Alembic Pharmaceuticals incorporates s
Alembic Pharmaceuticals incorporated a subsidiary named Alembic Pharmace..

10Mar Alembic Pharmaceuticals surges on inco
Alembic Pharmaceuticals is currently trading at Rs. 715.70, up by 9.30 p..

06Mar Alembic Pharmaceuticals informs about
Alembic Pharmaceuticals has informed that Alembic Therapeutics LLC, a st..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	1144.7	5031.19999999999
Gross Profit	1387.8	6085.89999999999
Operating Profit	2823.4	9492.69999999999
Net Sales	16422.4	60326.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2146.70 (3.09%)	M.Cap ( in Cr)1326.24
Hester Biosciences (BSE) 1427.90 (4.01%)	M.Cap ( in Cr)1214.70
Haleos Labs (BSE) 1299.00 (3.61%)	M.Cap ( in Cr)392.72
RPG Life Sciences (BSE) 1922.95 (2.35%)	M.Cap ( in Cr)3180.37
Albert David (BSE) 653.15 (6.34%)	M.Cap ( in Cr)372.76

Shareholding Pattern

	PROMOTERS	69.74%
	NON-INSTITUTION	9.86%
	MUTUAL FUNDS/UTI	8.22%
	FI/BANKS/INSURANCE	7.64%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	4.85
Aditya Birla SL Pha...	2.97
Kotak Small Cap Fund(G)	1.98
ICICI Pru Pharma He...	1.95
DSP Midcap Fund-Reg(G)	1.57
Bajaj Finserv Healt...	1.25
WOC Pharma and Heal...	1.20

Risk Disclosures on Derivatives

Smart Quotes

ALEMBIC PHARMACEUTICALS LTD.